SF767 人腦瘤細胞
Catalogue No.: C748
Product Format: a T25 flask
Culture Properties：貼壁
Complete Growth Medium: 89%H-DMEM+10%FBS+1%雙抗
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Application: Cells and cancer research
NOTE: FOR RESEARCH USE ONLY.

Components

SCLC cases, respectively, and CD8+ TILs were present in 59% of SCLC samples (32). Hui Yuetal. reported that the overall prevalence of PD-L1 expression was 16.5% in tumor cells and 44.8% in tumor-in?ltrating immune cells in their SCLC cohort (33). In our study, PD-L1 was expressed on tumor cells in two thymic NEC cases (2/7, 28.6%) and on tumor-in?ltrating immune cells in three thymic NEC cases (3/7, 42.9%),which are comparable with the frequency of PD-L1